HeartBeam, Inc. (BEAT): Nasdaq/NYSE listing notice — HeartBeam receives Nasdaq deficiency notice for failing minimum $2.5M equity requirement

HeartBeam, Inc.

Reported stockholders' equity of $2.374M as of Dec 31, 2022, below the $2.5M minimum.
Company has 45 days (until May 4, 2023) to submit a compliance plan to Nasdaq.
If plan accepted, HeartBeam has until Sept 18, 2023 to regain compliance.
Stock and warrants continue trading; delisting would materially affect capital access.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HeartBeam, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)(1)

Exact text from the filing

March 20, 2023, HeartBeam, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December 31, 2022, the Company reported stockholders’ equity of $2,374,000, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the Company’

View on SEC.gov

Browse all listing & compliance notices →

HeartBeam, Inc. filing history →

Source: SEC EDGAR

accession 0001779372-23-000007

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.